The effect of intracochlearly administered acetylcholine-blocking agents on the efferent synapses of the cochlea.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000008:administration & dosage; D002415:Cats; D002794:Choline / Q000008:administration & dosage; D003051:Cochlea; D003056:Cochlear Nerve / Q000187:drug effects*; D003472:Curare / Q000008:administration & dosage; D005703:Gallamine Triethiodide / Q000008:administration & dosage; D006426:Hemicholinium 3 / Q000008:administration & dosage; D006584:Hexamethonium Compounds / Q000008:administration & dosage; D007267:Injections; D007761:Labyrinthine Fluids; D008464:Mecamylamine / Q000008:administration & dosage; D009433:Neural Inhibition; D009476:Neurons, Efferent / Q000187:drug effects / Q000502:physiology; D013331:Strychnine / Q000008:administration & dosage; D013390:Succinylcholine / Q000008:administration & dosage; D013569:Synapses / Q000187:drug effects* / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*
D006584:Hexamethonium Compounds; D006426:Hemicholinium 3; D008464:Mecamylamine; D001285:Atropine; D003472:Curare; D013331:Strychnine; D013390:Succinylcholine; D002794:Choline; D000109:Acetylcholine; D005703:Gallamine Triethiodide